SCHEDULE: PRIMECAP Management Updates GRAIL Stake to 4.72%

PRIMECAP Management Co./CA/ has filed an Amendment No. 2 to its Schedule 13G, reporting a beneficial ownership of 4.72% in GRAIL, Inc. as of December 31, 2025.

Summary

• PRIMECAP Management Co./CA/ reported beneficial ownership of 1,838,684 shares of GRAIL, Inc. common stock.
• This represents 4.72% of GRAIL, Inc.'s outstanding common stock.
• PRIMECAP holds sole voting power over 1,836,818 shares and sole dispositive power over 1,838,684 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive update, confirming a significant institutional investor's continued, albeit passive, stake in GRAIL, Inc. The filing itself is routine for beneficial ownership disclosures.

Positives

• PRIMECAP Management Co./CA/, a significant investment adviser, maintains a substantial stake in GRAIL, Inc., indicating continued institutional interest in the company.

Negatives

• The reported ownership of 4.72% is below the 5% threshold, which could imply a reduction in stake from a previous filing, though the prior percentage is not disclosed in this document.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding GRAIL, Inc.'s future performance or operations.

Industry Context

StockSavvy.ai notes that institutional ownership disclosures like this Schedule 13G provide transparency into significant investor positions, which can influence market perception and liquidity. While PRIMECAP's stake is below the 5% threshold, its continued presence as a major holder in GRAIL, Inc. is noteworthy within the biotechnology and healthcare investment landscape.

Comparison to Industry Standards

• PRIMECAP Management Co./CA/ is a well-known investment adviser, and its holdings are often benchmarked against other large institutional investors like Vanguard, BlackRock, or Fidelity, which frequently disclose passive stakes in public companies via Schedule 13G filings.
• A 4.72% stake, while significant, is below the 5% threshold that would trigger a more detailed Schedule 13D filing, indicating a passive investment intent, consistent with typical investment adviser strategies rather than activist investing.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional investor's position, potentially influencing investor confidence.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership by an investment adviser. It confirms PRIMECAP Management's continued passive stake in GRAIL, Inc. at 4.72%. While it indicates ongoing institutional interest, it does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

GRAIL Inc., PRIMECAP Management, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, SEC Filing, Institutional Ownership